Global Infant Nutrition Market to Register Substantial Expansion by 2025
Growing consumer base and economy of emerging countries would play a major role in the growth of infant nutrition market in the near future:
In the next few years, it is expected that the global infant nutrition market will show healthy growth. In the last few years the sale of infant nutrition products in developed countries has shown single digit growth rate. As the slowly increasing population, low birth rate and due to market saturation. In case of emerging countries, the market has grown by double digit rate due to increasing population and economy of the countries at high rates and increasing awareness about infant nutrition.
China holds the largest market share in APAC region as it has the highest birthrate and the companies are focusing on the sale of premium products in China, considering its growing economy and growing income of the middle class population.
Infant Nutrition Market Dynamics
According to the Center for Disease Control and Prevention, the total number of births in the U.S. in 2014 was 3,988,076. The birth rate was 12.5 per 1000 people in the region. Moreover, the general fertility increased to 62.9% per 1000 women in the age group of 15 to 44. This rise in fertility is an indicator of the increased birth rate. Owing to the above mentioned reasons, the global infant nutrition market is estimated to grow at a considerable rate over the forecast period.
According to the worldstat.org, the birth rate in Asia was 17.56 in 2011. The birth rate of boys was more than the birth rate of girls in this region. The population of Asia has risen from 4.16 billion in 2010 to 4.43 billion in 2016, which is an increase of around 266 million. This rise in the number of births along with the rise in disposable income and per capita spending on baby care have made the infant nutrition market in this region, a promising one. A new trend observed in the market is that of increasing consumer inclination towards organic infant nutrition products.
To get holistic SAMPLE of the report including table of contents, please click: https://www.coherentmarketinsights.com/insight/request-sample/400
Stringent regulatory scenario, creates high entry barrier for new entrants in the market. As per the data of China Certification and Accreditation Administration (CNCA), after implementation of quality and safety standards in 2013, out of over 800 foreign brands selling their product of infant formula, only 94 have received approval to sell their products in China and only two-thirds of the local Chinese have received production permit renewals, who has their infant formula products.
Some major players in this market include Nestle, Mead Johnson Nutrition, Bledina, DANONE, Meiji Holdings Co. Ltd, Abbott Nutrition, The Kraft Heinz Company, FrieslandCampina, and Beingmate Baby & Child Food Co. Ltd.
The Mead Johnson Nutrition and Abbott Nutrition holds the largest market share with their Enfamil and Similac brands.
Ask for Customization of Research [email protected] https://www.coherentmarketinsights.com/insight/request-customization/400
In 2012, Nestle bought Pfizer’s baby food division for US$11.9 billion. This acquisition helped Nestle to expand its reach into emerging markets, as Pfizer had large market share in countries such as India and China.
You may be interested
Hepatitis Vaccine Market To Propel Growth Based on Rising Demand For Growing Consumer Preferences In Pharma | CMI ResearchAlbert R - October 19, 2018
The Hepatitis Vaccine Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently released Hepatitis Vaccine…
Increasing Awareness Of Home-Based Treatments Is A Prominent Factor To Fuel The Remote Patient Monitoring Devices MarketMohit Joshi - October 19, 2018
The Remote Patient Monitoring Devices Market is expected to have a highly positive growth outlook from 2018-2025 according to a recently released Remote Patient Monitoring Devices Market research…
Tuberculosis Vaccine Market To Propel Growth Based on Rising Demand For Growing Consumer Preferences In Pharma | CMI ResearchAlbert R - October 19, 2018
The Tuberculosis Vaccine Market is expected to have a highly positive outlook for the next five years 2018 – 2026 according to a recently released Tuberculosis Vaccine…